OOIR: Observatory of International Research

Papers

(The H4-Index of Journal of Neuroendocrinology is 30. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
Melatonin receptors and thyroid stimulating hormone in the equine pars tuberalis: Potential modulators of seasonal reproduction in the mare	162
Prevalence of metastases outside the liver and abdominal lymph nodes on ⁶⁸Ga‐DOTATOC‐PET/CT in patients with small intestinal and pancreatic neuroendocrine tumours	147
The ins and outs of the caudal nucleus of the solitary tract: An overview of cellular populations and anatomical connections	125
Prognostic value of inflammation‐related biomarkers in patients with gastroenteropancreatic neuroendocrine neoplasms: A systematic review and meta‐analysis	115
Microbes, oxytocin and stress: Converging players regulating eating behavior	114
Brain circuits for maternal sensitivity and pain involving anterior cingulate cortex among mothers receiving buprenorphine treatment for opioid use disorder	112
New insights in cellular senescence: The pituitary model	102
Enhanced pup retrieval behaviour in a mouse model of polycystic ovary syndrome	62
Transient loss of satiety effects of leptin in middle‐aged male mice	54
PRRT in high‐grade digestive neuroendocrine neoplasms (NET G3 and NEC)	52
Nitric oxide synthase contributes to the maintenance of LTP in the oxytocin–mRFP1 neuron of the rat hypothalamus	49
	41
Dopamine and prolactin in migraine: Mechanisms and potential therapeutic targets	40
	38
	38
	37
Neuroendocrine tumours and pregnancy: Real‐world data from an European Neuroendocrine Tumour Centre of Excellence	36
Optimal follow‐up with somatostatin receptor PET/CT imaging in patients with small intestinal neuroendocrine tumours	36
Relationship between somatostatin receptor expressing tumour volume and health‐related quality of life in patients with metastatic GEP‐NET	36
Volumetric parameters from [¹⁸F]FDG PET/CTpredicts survival in patients with high‐grade gastroenteropancreatic neuroendocrine neoplasms	35
Efficacy of first‐line checkpoint inhibitors in combination with chemotherapy in high‐grade extrapulmonary metastatic neuroendocrine carcinomas	34
Early corticosterone increases vocal complexity in a wild parrot: An organizational role of the hypothalamic–pituitary–adrenal axis in vocal learning?	33
Quality of life as a predictor for survival in patients with small intestinal neuroendocrine tumours	33
Prenatal androgenization causes expression changes of progesterone and androgen receptor mRNAs in the arcuate nucleus of female mice across development	33
Duodenal neuroendocrine neoplasms with unexpectedly aggressive behaviour: Challenging the “watch and wait” approach	33

Abstracts	32
Synthetic neuroactive steroids as new sedatives and anaesthetics: Back to the future	31
Understanding negative feedback: Changes in high‐molecular‐weight adrenocorticotropic hormone in adrenocorticotropic hormone‐independent Cushing's syndrome	30
The role of gonadotropin‐releasing hormone neurons in polycystic ovary syndrome	30
Sexually dimorphic effects of estrogen receptor 2 deletion in the dorsal raphe nucleus on emotional behaviors	30